234 related articles for article (PubMed ID: 34321320)
1. PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.
Jo A; Lee Y; Kam TI; Kang SU; Neifert S; Karuppagounder SS; Khang R; Kang H; Park H; Chou SC; Oh S; Jiang H; Swing DA; Ham S; Pirooznia S; Umanah GKE; Mao X; Kumar M; Ko HS; Kang HC; Lee BD; Lee YI; Andrabi SA; Park CH; Lee JY; Kim H; Kim H; Kim H; Cho JW; Paek SH; Na CH; Tessarollo L; Dawson VL; Dawson TM; Shin JH
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321320
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosylated PARIS Leads to the Sequestration of PGC-1α into Insoluble Deposits in Parkinson's Disease Model.
Kim H; Lee JY; Park SJ; Kwag E; Kim J; Shin JH
Cells; 2022 Nov; 11(22):. PubMed ID: 36429110
[TBL] [Abstract][Full Text] [Related]
3. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
[TBL] [Abstract][Full Text] [Related]
4. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
[TBL] [Abstract][Full Text] [Related]
5. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
Kang H; Shin JH
Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
[TBL] [Abstract][Full Text] [Related]
6. Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate.
Bae JH; Jo A; Cho SC; Lee YI; Kam TI; You CL; Jeong HJ; Kim H; Jeong MH; Jeong Y; Ha YW; Kim YS; Kim J; Woo SH; Kim MS; Shin ES; Song SO; Kang H; Khang R; Park S; Park J; Dawson VL; Dawson TM; Park SC; Shin JH; Kang JS
Sci Transl Med; 2023 Aug; 15(711):eabh3489. PubMed ID: 37647389
[TBL] [Abstract][Full Text] [Related]
7. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid.
Lin CY; Huang YN; Fu RH; Liao YH; Kuo TY; Tsai CW
Phytomedicine; 2021 Jan; 80():153369. PubMed ID: 33070082
[TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
Khang R; Park C; Shin JH
Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
[TBL] [Abstract][Full Text] [Related]
10. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
[TBL] [Abstract][Full Text] [Related]
11. Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.
Kim H; Shin JY; Jo A; Kim JH; Park S; Choi JY; Kang HC; Dawson VL; Dawson TM; Shin JH; Lee Y
Brain; 2021 Dec; 144(12):3674-3691. PubMed ID: 34581802
[TBL] [Abstract][Full Text] [Related]
12. Identification of transketolase as a target of PARIS in substantia nigra.
Kim H; Kang H; Lee Y; Park CH; Jo A; Khang R; Shin JH
Biochem Biophys Res Commun; 2017 Nov; 493(2):1050-1056. PubMed ID: 28939041
[TBL] [Abstract][Full Text] [Related]
13. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.
Stevens DA; Lee Y; Kang HC; Lee BD; Lee YI; Bower A; Jiang H; Kang SU; Andrabi SA; Dawson VL; Shin JH; Dawson TM
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11696-701. PubMed ID: 26324925
[TBL] [Abstract][Full Text] [Related]
14. Decoding the Parkinson's Symphony: PARIS, Maestro of Transcriptional Regulation and Metal Coordination for Dopamine Release.
Hwang Y; Mohammad Mydul Islam AK; Park S; Kang HG; Lee C; Lim MH; Lee SJ
ACS Chem Neurosci; 2024 Feb; 15(3):447-455. PubMed ID: 38241020
[TBL] [Abstract][Full Text] [Related]
15. PGC-1α Promoter Methylation in Parkinson's Disease.
Su X; Chu Y; Kordower JH; Li B; Cao H; Huang L; Nishida M; Song L; Wang D; Federoff HJ
PLoS One; 2015; 10(8):e0134087. PubMed ID: 26317511
[TBL] [Abstract][Full Text] [Related]
16. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
[TBL] [Abstract][Full Text] [Related]
17. Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation.
Yazar V; Kang SU; Ha S; Dawson VL; Dawson TM
Sci Rep; 2021 Nov; 11(1):21500. PubMed ID: 34728675
[TBL] [Abstract][Full Text] [Related]
18. Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.
Kumar M; Acevedo-Cintrón J; Jhaldiyal A; Wang H; Andrabi SA; Eacker S; Karuppagounder SS; Brahmachari S; Chen R; Kim H; Ko HS; Dawson VL; Dawson TM
Stem Cell Reports; 2020 Sep; 15(3):629-645. PubMed ID: 32795422
[TBL] [Abstract][Full Text] [Related]
19. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection.
Kang H; Khang R; Ham S; Jeong GR; Kim H; Jo M; Lee BD; Lee YI; Jo A; Park C; Kim H; Seo J; Paek SH; Lee YS; Choi JY; Lee Y; Shin JH
Oncotarget; 2017 Jul; 8(30):48603-48618. PubMed ID: 28611284
[TBL] [Abstract][Full Text] [Related]
20. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]